Literature DB >> 27153283

Inducing tolerance one antigen at a time.

Rafael M Rezende1, Howard L Weiner1.   

Abstract

Mesh：

Substances：

Year:  2016        PMID： 27153283     DOI： 10.1038/nbt.3573

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  9 in total

1.  Reversal of autoimmunity by boosting memory-like autoregulatory T cells.

Authors:  Sue Tsai; Afshin Shameli; Jun Yamanouchi; Xavier Clemente-Casares; Jinguo Wang; Pau Serra; Yang Yang; Zdravka Medarova; Anna Moore; Pere Santamaria
Journal:  Immunity       Date:  2010-04-08       Impact factor: 31.745

Review 2.  Oral tolerance.

Authors:  Howard L Weiner; Andre Pires da Cunha; Francisco Quintana; Henry Wu
Journal:  Immunol Rev       Date:  2011-05       Impact factor: 12.988

Review 3.  DNA-based vaccines for multiple sclerosis: current status and future directions.

Authors:  Nicolas Fissolo; Xavier Montalban; Manuel Comabella
Journal:  Clin Immunol       Date:  2010-12-15       Impact factor: 3.969

4.  Antigen-specific tolerance by autologous myelin peptide-coupled cells: a phase 1 trial in multiple sclerosis.

Authors:  Andreas Lutterotti; Sara Yousef; Andreas Sputtek; Klarissa H Stürner; Jan-Patrick Stellmann; Petra Breiden; Stefanie Reinhardt; Christian Schulze; Maxim Bester; Christoph Heesen; Sven Schippling; Stephen D Miller; Mireia Sospedra; Roland Martin
Journal:  Sci Transl Med       Date:  2013-06-05       Impact factor: 17.956

5.  Microparticles bearing encephalitogenic peptides induce T-cell tolerance and ameliorate experimental autoimmune encephalomyelitis.

Authors:  Daniel R Getts; Aaron J Martin; Derrick P McCarthy; Rachael L Terry; Zoe N Hunter; Woon Teck Yap; Meghann Teague Getts; Michael Pleiss; Xunrong Luo; Nicholas J C King; Lonnie D Shea; Stephen D Miller
Journal:  Nat Biotechnol       Date:  2012-11-18       Impact factor: 54.908

6.  Cutting edge: IL-27 induces the transcription factor c-Maf, cytokine IL-21, and the costimulatory receptor ICOS that coordinately act together to promote differentiation of IL-10-producing Tr1 cells.

Authors:  Caroline Pot; Hulin Jin; Amit Awasthi; Sue Min Liu; Chen-Yen Lai; Rajat Madan; Arlene H Sharpe; Christopher L Karp; Shi-Chuen Miaw; I-Cheng Ho; Vijay K Kuchroo
Journal:  J Immunol       Date:  2009-07-01       Impact factor: 5.422

7.  Transdermal application of myelin peptides in multiple sclerosis treatment.

Authors:  Agata Walczak; Malgorzata Siger; Agnieszka Ciach; Marian Szczepanik; Krzysztof Selmaj
Journal:  JAMA Neurol       Date:  2013-09-01       Impact factor: 18.302

8.  Expanding antigen-specific regulatory networks to treat autoimmunity.

Authors:  Xavier Clemente-Casares; Jesus Blanco; Poornima Ambalavanan; Jun Yamanouchi; Santiswarup Singha; Cesar Fandos; Sue Tsai; Jinguo Wang; Nahir Garabatos; Cristina Izquierdo; Smriti Agrawal; Michael B Keough; V Wee Yong; Eddie James; Anna Moore; Yang Yang; Thomas Stratmann; Pau Serra; Pere Santamaria
Journal:  Nature       Date:  2016-02-17       Impact factor: 49.962

9.  The cellular and molecular mechanisms of immuno-suppression by human type 1 regulatory T cells.

Authors:  Silvia Gregori; Kevin S Goudy; Maria Grazia Roncarolo
Journal:  Front Immunol       Date:  2012-02-29       Impact factor: 7.561
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.